Nutritional Formulation for Patients with Angelman Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study of Exogenous Ketones.

Robert P CarsonDonna L HerberZhaoxing PanFenna PhibbsAlexandra P KeyArnaud GouellePatience ErgishEric A ArmourShital PatelJessica Duis

Published in: The Journal of nutrition (2022)

The exogenous KF appears safe. More data are needed to determine the utility of exogenous ketones as a nutritional approach in children with AS.This trial was registered at clinicaltrials.gov as NCT03644693.

Keyphrases

double blind
phase iii
clinical trial
study protocol
phase ii
placebo controlled
young adults
drug delivery
randomized controlled trial
open label
deep learning